nelfinavir has been researched along with Melanoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Castiello, L; Ferrari, M; Hiscott, J; Jakobsen, M; Krapp, C; Muscolini, M; Olagnier, D; Palermo, E; Peruzzi, G; Santoni, A; Vulpis, E; Zevini, A; Zingoni, A | 1 |
Arozarena, I; Brunton, H; Cooper, ZA; Dummer, R; Ferguson, J; Flaherty, KT; Frederick, DT; Girotti, MR; Lee, JL; Levesque, MP; Marais, R; Miskolczi, Z; Rowling, EJ; Smith, MP; Wargo, JA; Wellbrock, C | 1 |
Flaherty, KT; Jiang, W; Lei, H; Mikochik, PJ; Ra, JH; Spitz, FR; Winkler, JD | 1 |
3 other study(ies) available for nelfinavir and Melanoma
Article | Year |
---|---|
An optimized retinoic acid-inducible gene I agonist M8 induces immunogenic cell death markers in human cancer cells and dendritic cell activation.
Topics: Alarmins; Antigen Presentation; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Calreticulin; Caspase 3; Cell Differentiation; Cell Line, Tumor; DEAD Box Protein 58; Dendritic Cells; HMGB1 Protein; Humans; Immunization; Interferons; Melanoma; Molecular Targeted Therapy; Nelfinavir; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Receptors, Immunologic; Signal Transduction | 2019 |
Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy.
Topics: Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Tolerance; GTP Phosphohydrolases; HIV Protease Inhibitors; Humans; Melanoma; Membrane Proteins; Mitogen-Activated Protein Kinases; Mutation; Nelfinavir; Paired Box Transcription Factors; PAX3 Transcription Factor; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Up-Regulation | 2016 |
HIV protease inhibitor nelfinavir inhibits growth of human melanoma cells by induction of cell cycle arrest.
Topics: Apoptosis; cdc25 Phosphatases; Cell Growth Processes; Cell Line, Tumor; Colonic Neoplasms; Cyclin-Dependent Kinase 2; G1 Phase; HIV Protease Inhibitors; Humans; Melanoma; Nelfinavir; Phosphorylation; Proto-Oncogene Proteins c-akt; Retinoblastoma Protein; Signal Transduction | 2007 |